In trials to find possible treatments for long COVID, the NIH’s RECOVER initiative includes studies with exercise therapy tests. Critics of the exercise trials say the tests could cause more harm to long COVID patients with post-exertional malaise, a worsening of symptoms such as fatigue and cognitive issues after exercise.
One organization, Long COVID Justice, launched a petition against the trials.
“We are, frankly, horrified,” said JD Davids, co-founder of Long COVID Justice, about the “misguided trials.”
#MEAction USA, an international advocacy group, sent multiple letters to NIH asking for the NIH’s reasoning.
NIH told Nature that the exercise trial would use “inclusion and exclusion criteria to make sure that people who could be harmed by exercise will not be included in that platform trial.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
